It is worth noting that the ratio of P-NF-κB p65/NF-κB p65 was increased in the PCOS group and SGD treatment could significantly reduce the ratio, suggesting that the inflammation was triggered in PCOS group and SGD had the ability of inhibiting the phosphorylation of NF-κB p65. Here, NFKB1 is linked to polycystic ovary syndrome.